BioSpace News Archive

Business

Kallyope, Pioneers in Drug Discovery via the Gut-Brain Axis, Strengthens Senior Leadership Team with Key Appointments

“With novel compounds in two lead programs now in clinical development, this is an inflection point for Kallyope.

March 16, 2022
·
3 min read
OliX Pharmaceuticals Presents Potential Utility of GalNAc-asiRNA Platform at OPT Congress

OliX Pharmaceuticals, Inc. announced that Behfar Ardehali, Ph.D., Senior Scientist of the Company, presented at the 7th Annual OPT Congress Oligonucleotide & Precision Therapeutics.

March 16, 2022
·
1 min read
Business

ImmunoPrecise Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2022

IMMUNOPRECISE ANTIBODIES LTD. today announced financial results for third quarter fiscal year 2022, which ended January 31, 2022.

March 16, 2022
·
10 min read
Business

Tesis Biosciences Partners with Frontier Management to Provide Exclusive Pharmacogenetic Testing for Residents of Frontier’s Senior Living Facilities

Tesis Biosciences, the leader in targeted genetic sequencing, and Frontier Management, one of the largest senior housing providers in the U.S., have announced an agreement under which Tesis will be the exclusive provider of pharmacogenetic testing for residents of the company’s communities.

March 16, 2022
·
3 min read
Drug Development

Oramed Completes Patient Enrollment in Phase 2 Oral Insulin NASH Trial

Oramed Pharmaceuticals Inc. today announced it has completed enrollment of all patients in a Phase 2 trial of its oral insulin capsule ORMD-0801 for the treatment of non-alcoholic steatohepatitis (NASH).

March 16, 2022
·
5 min read
Genetown

Yield10 Bioscience Chief Executive Officer Dr. Oliver Peoples to Present on Development of Camelina Crop for Use in Biofuels at ABLC 2022 Conference

Yield10 Bioscience, Inc. today announced that its Chief Executive Officer Dr. Oliver Peoples, Ph.D. will present at the Advanced Bioeconomy Leadership Conference 2022 (“ABLC”) being held at the Mayflower Hotel in Washington D.C. March 16-18, 2022.

March 16, 2022
·
6 min read
Business

Alaunos Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results on March 30, 2022

Alaunos Therapeutics, Inc. today announced that it will report financial results for the fourth quarter ended December 31, 2021 on Wednesday, March 30, 2022, before the open of U.S. markets.

March 16, 2022
·
1 min read
Press Releases

Sana Biotechnology Reports Fourth Quarter and Full Year 2021 Financial Results and Business Updates

Sana Biotechnology, Inc. today reported financial results and business highlights for the fourth quarter and year ended December 31, 2021.

March 16, 2022
·
21 min read
Biotech Beach

LIXTE Biotechnology Holdings, Inc. to Present at MedInvest Pharmaceutical and Biotechnology Investor Conference

LIXTE Biotechnology Holdings, Inc. will present at the MedInvest Pharmaceutical and Biotechnology Investor Conference to be held March 28 - April 1, 2022.

March 16, 2022
·
3 min read
Business

Radius Health Announces Leadership Appointments

Radius Health, Inc., announced appointments to new roles on its executive leadership team, effective immediately.

March 16, 2022
·
2 min read